Could a natural Fat-Like molecule curb alcohol cravings in young adults?

NCT ID NCT07503782

Not yet recruiting Disease control Sponsor: Medical University of South Carolina Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Aug 13, 2026 · Updated 3 times

Summary

This study tests whether a natural molecule called oleoylethanolamide (OEA) can reduce inflammation, improve thinking, and lower alcohol use in young adults aged 18–25 with alcohol use disorder. Participants will take OEA or a placebo daily for 6 weeks and provide blood, saliva, and urine samples. The goal is to see if OEA offers a new way to help manage alcohol problems.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: oleoylethanolamide (OEA), a natural fat-like molecule
What this could lead to: If it works, this could point toward a new, non-addictive treatment to help young adults reduce alcohol use by targeting inflammation and brain function.
What could go wrong: This is a small, early-stage pilot trial with only 42 participants. It may not show clear benefits, and results may not apply to older adults or more severe cases.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALCOHOL USE DISORDER (AUD) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

alcohol abuse

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ALCOHOL USE DISORDER (AUD)

Contacts and locations

Locations

Medical University of South Carolina

Charleston, South Carolina, 29425, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.